Viroprev™

Viroprev™ for the safe, effective treatment of Hepatitis C, and HIV. Viroprev™ is a highly specific human monoclonal antibody that has been shown in human tumor xenografts to safely and effectively treat Hepatitis C and HIV by selectively targeting infected tissue while leaving normal tissue unharmed.

Viroprev™ is in the IND application stage and is prepared to proceed to human clinical trials. Viroprev™ is being developed as a monoclonal antibody based therapy that specifically targets virally infected cells, such as Hepatitis C and HIV, and has shown to keep healthy cells in tact in all pre-clinical testing.

Viroprev™ product development stage

Click the above image to open a larger version in a new window.